Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.

Date publication

janvier 2015

Journal

PloS one

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COTTIN Yves , Pr VERGELY Catherine , Pr LORGIS Luc

Tous les auteurs :
Stamboul K, Lorin J, Lorgis L, Guenancia C, Beer JC, Touzery C, Rochette L, Vergely C, Cottin Y, Zeller M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/26158510

Résumé

Atrial fibrillation (AF), whether silent or symptomatic, is a frequent and severe complication of acute myocardial infarction (AMI). Asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor, is a risk factor for endothelial dysfunction. We addressed the relationship between ADMA plasma levels and AF occurrence in AMI.

Mots clés

Aged, Aged, 80 and over, Arginine, analogs & derivatives, Atrial Fibrillation, physiopathology, Biomarkers, blood, Chromatography, High Pressure Liquid, Electrocardiography, Endothelium, physiopathology, Female, Humans, Logistic Models, Male, Middle Aged, Multivariate Analysis, Myocardial Infarction, physiopathology, Oxidative Stress, Risk Assessment, methods, Risk Factors

Référence

PLoS ONE. 2015 ;10(7):e0131439